1000009773

Gujarat Themis Biosyn

283.20
-13.40 (-4.52%) tick NSE

Last updated on 25 Apr 2025 03:34 PM

Returns
-8.98%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

3228.64

Earning Per Share

8.14

Dividend Yield

0.25%

P/E Ratio

48.66

P/B Ratio

14.45

Debt to Equity

0.01

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd.

Similar Companies